Integral Ad Science (NASDAQ:IAS) Price Target Raised to $13.00 at Morgan Stanley

Integral Ad Science (NASDAQ:IASGet Rating) had its price target upped by analysts at Morgan Stanley from $12.00 to $13.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Morgan Stanley’s price objective would indicate a potential upside of 36.99% from the stock’s previous close.

A number of other analysts have also recently commented on IAS. Raymond James reduced their target price on shares of Integral Ad Science from $15.00 to $12.00 and set a “strong-buy” rating for the company in a report on Friday, November 11th. Barclays upped their price target on shares of Integral Ad Science from $8.00 to $10.00 and gave the stock an “equal weight” rating in a research report on Friday, November 18th. Finally, Evercore ISI dropped their price target on shares of Integral Ad Science to $13.00 in a research report on Wednesday, November 16th. One investment analyst has rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Buy” and an average target price of $14.88.

Integral Ad Science Stock Up 1.4 %

Shares of IAS stock opened at $9.49 on Wednesday. Integral Ad Science has a 12 month low of $6.63 and a 12 month high of $20.39. The stock has a market cap of $1.46 billion, a P/E ratio of -949.00 and a beta of 1.51. The company has a current ratio of 3.67, a quick ratio of 3.67 and a debt-to-equity ratio of 0.30. The company has a 50 day simple moving average of $9.26 and a two-hundred day simple moving average of $8.78.

Insider Buying and Selling

In related news, CAO Anil Sukumaran sold 3,956 shares of the company’s stock in a transaction on Friday, December 16th. The shares were sold at an average price of $8.96, for a total transaction of $35,445.76. Following the completion of the transaction, the chief accounting officer now owns 55,055 shares in the company, valued at $493,292.80. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Over the last quarter, insiders sold 8,732 shares of company stock worth $79,331. 1.00% of the stock is owned by insiders.

Hedge Funds Weigh In On Integral Ad Science

Several institutional investors have recently bought and sold shares of IAS. Ameritas Investment Partners Inc. lifted its position in Integral Ad Science by 92.1% during the first quarter. Ameritas Investment Partners Inc. now owns 2,499 shares of the company’s stock valued at $34,000 after purchasing an additional 1,198 shares during the last quarter. Amalgamated Bank bought a new position in Integral Ad Science during the first quarter valued at $43,000. Tower Research Capital LLC TRC lifted its position in Integral Ad Science by 493.4% during the third quarter. Tower Research Capital LLC TRC now owns 8,581 shares of the company’s stock valued at $62,000 after purchasing an additional 7,135 shares during the last quarter. Pinnacle Wealth Planning Services Inc. bought a new position in Integral Ad Science during the third quarter valued at $77,000. Finally, Hsbc Holdings PLC bought a new position in Integral Ad Science during the third quarter valued at $82,000. Institutional investors own 96.83% of the company’s stock.

About Integral Ad Science

(Get Rating)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, Germany, Italy, Spain, Sweden, Singapore, Australia, France, Japan, Canada, India, and Brazil. The company provides IAS Signal, a cloud-based technology platform that offers actionable insights; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

Further Reading

Analyst Recommendations for Integral Ad Science (NASDAQ:IAS)

Receive News & Ratings for Integral Ad Science Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Integral Ad Science and related companies with MarketBeat.com's FREE daily email newsletter.